Q3 2025 GoodRx Holdings Inc Earnings Call Transcript

Nov 5, 2025 / 01:00 PM GMT

Release Date Price: $3.33 (+2.15%)

Transcript 10-Q8-K

Key Points

Positve

GoodRx Holdings Inc (GDRX) reported strong results in its manufacturer solutions segment with a 54% year-over-year revenue growth.
The company expanded its access and affordability programs with leading pharmaceutical manufacturers, including partnerships with Novo Nordisk and Amgen.
GoodRx Holdings Inc (GDRX) launched the RX Smart Saver counter solution at Kroger Pharmacies nationwide, enhancing its retail partnerships.
The company introduced a new brand campaign, the Savings Wrangler, which has increased unaided awareness and search volume for GoodRx.
GoodRx Holdings Inc (GDRX) is actively engaged with the administration on policy efforts, positioning itself as a key player in the evolving healthcare landscape.

Negative

The company faced a 9% decline in prescription transaction revenue, primarily due to Rite Aid store closures and lower transaction volume in its integrated savings program.
GoodRx Holdings Inc (GDRX) is navigating industry headwinds that have modestly impacted its results, including changes in reimbursement models at retail.
There is growing uncertainty around the future of health insurance coverage in the US, which could affect the company's market dynamics.
The company is reassessing its primary performance metrics as the business evolves, indicating potential challenges in measuring growth and profitability.
GoodRx Holdings Inc (GDRX) anticipates a sequential decline in fourth-quarter revenue due to the acceleration of manufacturer solutions deals that closed earlier than expected.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GDRX.OQ - Goodrx Holdings Inc
Q3 2025 GoodRx Holdings Inc Earnings Call
Nov 05, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, thank you for standing by and welcome to the Good Rx 3rd quarter 2025 earnings call. As a reminder, today's conference call is being recorded. I would now like to introduce your host for today's call, Aubrey Reynolds, director of investor relations. Miss Reynolds, you may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator. Good morning, everyone, and welcome to Votax's earnings conference call for the 3rd quarter 2025.

Joining me today are Wendy Barnes, our Chief Executive Officer, and Chris McGinnis, our Chief Financial Officer

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.